title: [Longidase in the treatment of chronic prostatitis].
abstract: Twenty eight patients with documented chronic prostatitis (CP) received standard therapy (a control group) while a study group of 28 patients received standard therapy plus a 10 longidase injections in a dose of 3000 IU. Treatment results showed that longidase is highly effective in bacterial and abacterial CP. Longidase addition to standard therapeutic methods significantly reduced the disease symptoms and regression of inflammatory-proliferative alterations in the prostate. Thus, a domestic drug longidase is effective and safe in CP. It can be widely used in combined therapy of CP.
authors.forename: D Iu
authors.initials: DIu
authors.lastname: Pushkar'
authors.forename: A V
authors.initials: AV
authors.lastname: Zaĭtsev
authors.forename: A S
authors.initials: AS
authors.lastname: Segal
mesh_terms: D000328:Adult; D002908:Chronic Disease; D004337:Drug Carriers; D004359:Drug Therapy, Combination; D006801:Humans; D006821:Hyaluronoglucosaminidase / Q000737:chemistry / Q000627:therapeutic use*; D007958:Leukocyte Count; D008297:Male; D008875:Middle Aged; D009930:Organic Chemicals; D011472:Prostatitis / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000382:microbiology; D016896:Treatment Outcome; D014463:Ultrasonography
chemical_list: D004337:Drug Carriers; D009930:Organic Chemicals; C089921:polyoxydonium; D006821:Hyaluronoglucosaminidase